Introduction
Treated patients with Parkinson's disease (PD) have increased susceptibility to impulse control disorders with pathological gambling, compulsive shopping and hypersexuality found in approximately 14% of patients.
1,2 Dopamine replacement therapies, especially dopamine agonist therapies, are associated with an increased risk for impulse control disorders in patients with PD, and management strategies include using the lowest effective doses of such therapies. [3] [4] [5] Because of the high affinity of some dopamine agonists for autoreceptors, [3] [4] [5] the regulation of intact dopamine neurons by dopamine agonists is a current focus of research. Recent studies show that the mechanism of dopamine release in the terminals and in the midbrain cell body regions is similar, relying on both diffusion and reuptake through dopamine transporters, 6 and that impulsivity and novelty seeking traits may be mediated by D2 and D3 dopamine autoreceptors within the medial dopamine cell populations of the midbrain. 7 These neurons innervate the ventral striatum and are located within the ventral tegmental area (VTA) and medial substantia nigra pars compacta (SNC, Figure 1 ), 7 which we term the midbrain impulse control region. These cell groups are largely spared in patients with PD, 8, 9 and recent studies show increased dopamine receptor binding in midbrain dopamine cell groups in patients with PD and in individuals with impulse control disorders. Mechanisms for dopamine release from cell bodies and dendrites have been localized in human midbrain neurons, [11] [12] [13] [14] [15] but it remains unclear which dopamine receptors are expressed on midbrain dopamine neurons. The excitatory D1-like receptor family (dopamine receptors D1 and D5) 16 are found on at least some midbrain dopamine neurons, 17 including in human brain. [18] [19] [20] [21] [22] The D2-like family (D2, D3 and D4 dopamine receptors) are primarily inhibitory autoreceptors on dopamine neurons, 17, [23] [24] [25] [26] and it is these receptors that have been the focus of research on impulse control disorders. [3] [4] [5] Studies in monkeys have clearly shown different reactions of midbrain dopamine neurons to motivational signals, 27 and 5 these reactions are likely to occur via different receptor types. There have been no previous studies analyzing the cellular location of all these dopamine receptors and transporters in the impulse control region of the human midbrain. As the different responses at these dopamine receptors are considered to underlie impulse control disorders, identifying the types of dopamine receptors in intact dopamine neurons in the midbrain impulse control region is important, and the focus of this study. Fluorescent images were captured at 40X using a Nikon Microscope ECLIPSE 90i confocal microscope with a Nikon D-ECLIPSE C1 high-resolution camera. Colour images for display purposes were converted from red-green to magenta-green using Adobe Photoshop CS4. 
Methods

Human brain samples -
Quantification of the proportion of dopamine neurons in different midbrain
Analysis of the amount of comparative protein immunoflourescence in different dopamine
neuron types -was performed by a single investigator (SR) using the same sampling procedure and statistical analysis described above. The intensity of cellular immunoreactivity for each protein of interest within each dopamine neuron was assessed relative to the intensity of its cellular TH immunoreactivity, as recently described in detail. 30 Briefly, highresolution grey-scale images of double-labeled neurons were captured separately for each channel and dichotomized using ImageJ-extracted intensities (0-255 scale) as being either strongly (>50% of cellular TH intensity) or weakly (<50% of cellular TH intensity) expressed using the relative intensity of the immunofluorescent signal.
Results
Cellular expression of dopamine receptor proteins in the adult human midbrain
As expected, 31,32 D2 and D3 receptors were found in the majority (>90%) of dopamine neurons in all SNC subregions as well as in the VTA ( Figure 2B and Table 1 ). Intense immunoreactivity for the D2 receptor was localised on the surfaces of the cell bodies and proximal dendrites of many dopamine neurons (Figures 2B,F,J,N and 3D). D3 receptor immunostaining had the same neuronal localization but was less intense and was also found on surrounding small glial-like structures ( Figure 2B ). No D4 immunoreactivity was found in any of the dopamine neurons of the midbrain. We also found variably intense D1 and faint D5 receptor immunohistochemistry on dopamine neurons in the same subregions ( Figure   2A and Table 1 ), substantiating previous studies using various other methods. 18, [20] [21] [22] 33 ••• Figure 2 and Table 1 about here***
As the intensity of dopamine receptor immunoreactivity was variable, further regional analysis of receptor staining intensity was performed. There were no differences between dopamine cell groups in the intensity of D3 or D5 receptor expression ( Table 1) . As expected, the majority of midbrain dopamine neurons had strong D2 receptor expression (>60%, Figure 2J ,N and Table 1 ). The greatest regional variability was observed for the intensity of D1 receptors ( Table 1 ).
• Figure 4C and Table 1 ). There was a strong trend (p=0.057) for the ventral SNC to have a 2.8±1.0 fold and 8.0±3.0 fold increase in the numbers of neurons strongly expressing functional DAT compared with the dorsal SNC and medial SNC/VTA respectively ( Figure 4B and Table 1 ). This confirms previous detailed studies on this transporter in the adult human SNC. and VMAT than VTA dopamine neurons. This data suggests that medial SNC neurons are likely to contain higher levels of vesicular (releasable) dopamine and to express a greater concentration of dopamine receptors and thus have the capacity to facilitate enhanced physiological effects. Overall, our data suggest that the effects of dopamine and its agonists in the impulse control region are unlikely to be uniform, confirming previously findings, 27 and that the expression of D1 receptors on the dopamine neurons of the medial SNC subregion could be of particular interest for activating, rather than inhibiting, dopamine pathways involved in impulse control.
The midbrain dopamine region identified as relevant for impulsivity contains two different types of dopamine neurons cytoarchitecturally. We show that dopamine neurons in these regions normally differ in their expression of dopamine receptors and transporters.
While both the medial SNC and VTA have reciprocal projections with limbic regions, and especially the ventral striatum, they provide largely separate projection systems to the ventromedial (medial olfactory tubercle and medial nucleus accumbens shell) and ventrolateral (accumbens core, lateral shell and lateral tubercle) striatum respectively. 40 These two dopamine pathways from the midbrain impulse control region are thought to mediate different aspects of reward, 40 with the medial projection system important for the regulation of arousal characterized by affect and drive, and the two systems playing different roles in goal-directed learning. Our data show that the effect of dopamine and dopamine agonists on these different reward pathways is likely to vary substantially. Disinhibition of medial SNC neurons activates dopamine release 41 which would activate their D1 receptors and the ventrolateral striatal pathway directly. SNC neurons are known to differ from VTA neurons in having higher frequency pacemaker firing patterns, while VTA neurons discharge more irregularly. 42 The reduced expression of both D1 and D2 autoreceptors on VTA compared with other midbrain dopamine neurons indicates less autoinhibition, making these neurons more responsive to direct synaptic inputs. 41 The different behaviours and characteristics of the different dopamine responsive neurons within the midbrain impulse control region needs to be taken into account in further studies.
Impulse control disorders are increased in PD patients taking dopamine agonists, 43, 44 however only a minority of medicated PD patients exhibit impulse control disorders. [43] [44] [45] Recent studies have begun to address dopaminergic mechanisms related to this phenomenon, although few studies have assessed D1 receptor activity. PD patients with impulse control disorders have reduced D2/3 autoreceptor binding in the midbrain 10 and decreased ventral striatal DAT binding 46 and resting blood flow together with reduced dopamine modulation of activity during risk taking. 47, 48 They also have reduced striatal D2 autoreceptor binding 47 and a functional disconnection between the dorsal and ventral striatum. 49 As the reduction in both DAT and D2 receptor binding is more marked in the striatum in PD patients with impulse control disorders, and blood flow is reduced (marker of neuronal activity), these changes are likely to indicate a greater loss of dopamine-producing structures and therefore dopamine regulation of impulse control. While the impulse control region of the midbrain is relatively spared in PD, the medial SNC experiences variable loss, 38, [50] [51] [52] . Variability in medial SNC neuronal loss, in association with marked neuronal loss in the ventral SNC, may underlie the development of impulse control disorders in PD, a testable hypothesis. Greater loss of the ventrolateral striatal dopamine pathway would increase the relative activity of the ventromedial striatal dopamine pathway important for the regulation of reward-related arousal. A relative increase in activity in this reward pathway with its reduced dopamine receptor autoregulation, in association with disconnection from other striatal systems, may establish a mechanism by which impulse control is reduced following appropriate stimuli.
The tendency towards impulsive behaviour of the controls analysed in this study is unknown. Thus future comparative postmortem studies on individuals with variable known levels of impulsive behaviours are required to test our hypothesis. In this regard and of relevance to PD, the first cellular change associated with increasing levels of cellular α-synculein in midbrain dopamine neurons is reduced dopamine uptake that increases extracelllar dopamine levels. 53, 54 As age is the major predisposing factor for PD, we chose to assess older controls in this study to control for age as a predisposing factor with regard to cellular protein expression levels. Previous studies have shown reductions in DAT mRNA with ageing 55 but others show there is a preservation of the proteins involved in dopamine biosynthesis and compartmentation. 56 Importantly, we found a similar distribution of neurons expressing glycosylated DAT protein to that recently published, 36 with higher levels of the active form of DAT in the ventral SNC dopamine neurons that are more vulnerable to PD. We have demonstrated that DAT expression and DAT glycosylation is highly variable within the midbrain dopamine cell groups. The relationship between DAT and vulnerability to cell death in PD, and the low expression of this protein in reward-related dopamine pathways warrants further study. 
